SHARPIN and sarcoma: Analysis of a sarcoma-specific cohort (n = 265) revealed that SHARPIN gene amplification and/or high mRNA expression was significantly associated with shorter OS (p < 0.05) and PFS (p < 0.05) (Figure 3F,G).